Completed PHASE4 INTERVENTIONAL NCT00664222

Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)

Effects of Spironolactone on Insulin Resistance in Patients With Chronic Heart Failure

Sponsor: Tottori University Hospital

Interventions spironolactone + furosemide

Updated 5 times since 2017 Last updated: Apr 21, 2008 Started: Jan 31, 2004 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Stable Heart Failure, this trial is completed. The trial is conducted by Tottori University Hospital and has accumulated 5 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tottori University Hospital

Data source: Tottori University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.